-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On December 10, 2021, BenaGene, a leading domestic fourth-generation nanopore sequencing service company, completed a PreA round of strategic financing of RMB 25 million
Beina Gene was established in 2012 and is headquartered in Wuhan, focusing on the services and applications of the fourth-generation nanopore sequencing technology
In the next step, BenaGene plans to apply nanopore sequencing technology to the field of medical clinical testing
Dr.
Mr.
Kangsheng Global CEO Professor Huang Shiang said that in the fast-developing special inspection blue ocean market, Kangsheng Global has been committed to developing and introducing advanced technologies to respond to China's massive unmet medical needs
-END-
About Bena Gene
Wuhan Beina Technology Services Co.
The mission of Bena Gene is "sequencing computing enhances customer value, and gene decoding serves human health"; its vision is "a leader in multi-scenario sequencing applications"; its core values are "responsibility, integrity, learning, and innovation"
About Ruijiang Investment
Ruijiang Investment was established in 2012 and is headquartered in Wuhan, with branches and teams in Beijing, Shanghai, Chengdu and Hong Kong
The founder of the company graduated from the University of Chicago, and the company management team and investment team are composed of senior investors with international perspectives
About Kangsheng Global
Founded in 2003, Kangsheng Global is the first and leading independent clinical special inspection service provider in China
.
At present, Kangsheng Global has established a leading position in China's independent hematology clinical special inspection industry, providing one of the world's most extensive hematology testing portfolios
.
Provide hospitals, contract research institutions and pharmaceutical companies with a wide range of testing services, provide customers with a wide range of testing items and customized high-quality special tests in a cost-effective manner, and assist doctors in optimizing diagnosis, so as to choose personalized treatment plans for patients
.
